Cesare Gridelli

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gridelli Cesare; Maione Paolo; Rossi Antonio; Ferrara Marianna Luciana; Castaldo Vincenzo; Palazzolo Giovanni; Mazzeo Nicole
Treatment of advanced non-small-cell lung cancer in the elderly.
Rossi Antonio; Ricciardi Serena; Maione Paolo; de Marinis Filippo; Gridelli Cesare
Pemetrexed in the treatment of advanced non-squamous lung cancer.
Gridelli Cesare; Maione Paolo; Rossi Antonio; Palazzolo Giovanni; Colantuoni Giuseppe; Rossi Emanuela
Management of unfit older patients with advanced NSCLC.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Cesare Gridelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gridelli Cesare; Maione Paolo; Rossi Antonio; Ferrara Marianna Luciana; Castaldo Vincenzo; Palazzolo Giovanni; Mazzeo Nicole
Treatment of advanced non-small-cell lung cancer in the elderly.
Lung cancer (Amsterdam, Netherlands) 2009;66(3):282-6.
2009: Rossi Antonio; Ricciardi Serena; Maione Paolo; de Marinis Filippo; Gridelli Cesare
Pemetrexed in the treatment of advanced non-squamous lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(2):141-9.
2009: Gridelli Cesare; Maione Paolo; Rossi Antonio; Palazzolo Giovanni; Colantuoni Giuseppe; Rossi Emanuela
Management of unfit older patients with advanced NSCLC.
Cancer treatment reviews 2009;35(6):517-21.
2009: Maione Paolo; Rossi Antonio; Di Maio Massimo; Gridelli Cesare
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2009;66(1):8-14.
2009: Gridelli Cesare; Rossi Antonio; Maione Paolo; Ferrara Marianna Luciana; Castaldo Vincenzo; Sacco Paola Claudia
Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
The oncologist 2009;14(9):909-20.
2009: Gridelli Cesare; Maione Paolo; Ferrara Marianna Luciana; Rossi Antonio
Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer.
The oncologist 2009;14(6):601-11.
2009: Gridelli Cesare; Rossi Antonio; Maione Paolo; Rossi Emanuela; Castaldo Vincenzo; Sacco Paola Claudia; Colantuoni Giuseppe
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer.
The oncologist 2009;14(6):612-20.
2009: Di Maio Massimo; Chiodini Paolo; Georgoulias Vassilis; Hatzidaki Dora; Takeda Koji; Wachters Floris M; Gebbia Vittorio; Smit Egbert F; Morabito Alessandro; Gallo Ciro; Perrone Francesco; Gridelli Cesare
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Gridelli Cesare; Maione Paolo; Rossi Antonio; Ferrara Marianna Luciana; Bareschino Maria Anna; Schettino Clorinda; Sacco Paola Claudia; Ciardiello Fortunato
Potential treatment options after first-line chemotherapy for advanced NSCLC: maintenance treatment or early second-line?
The oncologist 2009;14(2):137-47.
2009: Gridelli Cesare; Maione Paolo; Rossi Antonio; Falanga Marzia; Bareschino Marianna; Schettino Clorinda; Colantuoni Giuseppe; Guerriero Ciro; Nicolella Dario; Rossi Emanuela; Ferrara Marianna Luciana; Palazzolo Giovanni
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Expert review of anticancer therapy 2009;9(1):115-24.
2009: Rossi A; Maione P; Ferrara M L; Sacco P C; Schettino C; Bareschino M A; Gridelli C
Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancer.
Current medicinal chemistry 2009;16(30):3919-30.
2008: Gridelli Cesare; Rossi Antonio; Maione Paolo
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.
Critical reviews in oncology/hematology 2008;68(1):29-36.
2008: Gridelli C; Rossi A; Maione P
Challenges treating older non-small cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii109-13.
2008: Rossi Antonio; Bria Emilio; Maione Paolo; Palazzolo Giovanni; Falanga Marzia; Gridelli Cesare
The role of cetuximab and other epidermal growth factor receptor monoclonal antibodies in the treatment of advanced non-small cell lung cancer.
Reviews on recent clinical trials 2008;3(3):217-27.
2008: Gridelli Cesare; De Maio Ermelinda; Barbera Santi; Sannicolo Mirella; Piazza Elena; Piantedosi FrancoVito; Brancaccio Luigi; Morabito Alessandro; Maione Paolo; Renda Francesco; Signoriello Giuseppe; Perrone Francesco;
The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.
Lung cancer (Amsterdam, Netherlands) 2008;61(1):67-72.
2008: Gridelli Cesare; Butts Charles; Ciardiello Fortunato; Feld Ronald; Gallo Ciro; Perrone Francesco
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial.
Clinical lung cancer 2008;9(4):235-8.
2008: Schettino Clorinda; Bareschino Maria A; Maione Paolo; Rossi Antonio; Ciardiello Fortunato; Gridelli Cesare
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer.
Current genomics 2008;9(4):252-62.
2008: Morgillo Floriana; Martinelli Erika; Troiani Teresa; Laus Gianluca; Pepe Stefano; Gridelli Cesare; Ciardiello Fortunato
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.
Molecular cancer therapeutics 2008;7(6):1698-707.
2008: Gridelli C; Maione P; Amoroso D; Baldari M; Bearz A; Bettoli V; Cammilluzzi E; Crinò L; De Marinis F; Di Pietro F A; Grossi F; Innocenzi D; Micali G; Piantedosi F V; Scartozzi M
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.
Critical reviews in oncology/hematology 2008;66(2):155-62.
2008: Gridelli Cesare
Targeted therapy developments in the treatment of non-small cell lung cancer: a promising but long and winding road.
Current opinion in oncology 2008;20(2):145-7.
2008: Gridelli Cesare; Maione Paolo; Rossi Antonio
The potential role of mTOR inhibitors in non-small cell lung cancer.
The oncologist 2008;13(2):139-47.
2008: Gridelli Cesare; Rossi Antonio; Maione Paolo; Ferrara Carmine; Del Gaizo Filomena; Guerriero Ciro; Nicolella Dario; Palazzolo Giovanni; Falanga Marzia; Colantuoni Giuseppe
New insights in drug development for the non-small cell lung cancer therapy.
Frontiers in bioscience : a journal and virtual library 2008;13():5108-19.
2007: Gridelli Cesare; Rossi Antonio; Morgillo Floriana; Bareschino Maria Anna; Maione Paolo; Di Maio Massimo; Ciardiello Fortunato
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamics.
Clinical lung cancer 2007;8(9):568-71.
2007: Gridelli Cesare; Maione Paolo; Rossi Antonio; De Marinis Filippo
The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments.
The oncologist 2007;12(10):1183-93.
2007: Gridelli Cesare; Rossi Antonio; Maione Paolo; Colantuoni Giuseppe; Del Gaizo Filomena; Ferrara Carmine; Nicolella Dario; Guerriero Ciro
Erlotinib in non-small-cell lung cancer.
Expert opinion on pharmacotherapy 2007;8(15):2579-92.
2007: Gridelli Cesare; Maione Paolo; Illiano Alfonso; Piantedosi Franco Vito; Favaretto Adolfo; Bearz Alessandra; Robbiati Sergio Federico; Filipazzi Virginio; Lorusso Vito; Carrozza Francesco; Iaffaioli Rosario Vincenzo; Manzione Luigi; Gallo Ciro; Morabito Alessandro; Perrone Francesco
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4663-9.
2007: Gridelli Cesare; Maione Paolo; Galetta Domenico; Colantuoni Guiseppe; Del Gaizo Filomena; Ferrara Carmine; Guerriero Ciro; Nicolella Dario; Rossi Antonio
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(8):758-61.
2007: Gridelli Cesare; Bareschino Maria Anna; Schettino Clorinda; Rossi Antonio; Maione Paolo; Ciardiello Fortunato
Erlotinib in non-small cell lung cancer treatment: current status and future development.
The oncologist 2007;12(7):840-9.
2007: Gridelli Cesare; Aapro Matti S; Barni Sandro; Beretta Giordano Domenico; Colucci Giuseppe; Daniele Bruno; Del Mastro Lucia; Di Maio Massimo; De Petris Luigi; Perrone Francesco; Thatcher Nick; De Marinis Filippo
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Critical reviews in oncology/hematology 2007;63(1):53-64.
2007: Gridelli Cesare; Ferrara Carmine; Guerriero Ciro; Palazzo Salvatore; Grasso Giuseppe; Pavese Ida; Satta Francesco; Bajetta Emilio; Cortinovis Diego; Barbieri Fausto; Gebbia Vittorio; Grossi Francesco; Novello Silvia; Baldini Editta; Gasparini Giampietro; Latino Walter; Durante Emilia; Giustini Lucio; Negrini Cristina
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):475-80.
2007: Gridelli Cesare; Gallo Ciro; Ceribelli Anna; Gebbia Vittorio; Gamucci Teresa; Ciardiello Fortunato; Carozza Francesco; Favaretto Adolfo; Daniele Bruno; Galetta Domenico; Barbera Santi; Rosetti Francesco; Rossi Antonio; Maione Paolo; Cognetti Francesco; Testa Antonio; Di Maio Massimo; Morabito Alessandro; Perrone Francesco;
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
2007: Gridelli Cesare; Rossi Antonio; Mongillo Floriana; Bareschino Maria; Maione Paolo; Ciardiello Fortunato
A randomized phase II study of sorafenib/gemcitabine or sorafenib/erlotinib for advanced non-small-cell lung cancer in elderly patients or patients with a performance status of 2: treatment rationale and protocol dynamics.
Clinical lung cancer 2007;8(6):396-8.
2007: Gridelli Cesare; Langer Corey; Maione Paolo; Rossi Antonio; Schild Steven E
Lung cancer in the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1898-907.
2007: Gridelli Cesare
Does palliative chemotherapy beyond three courses benefit patients with non-small-cell lung cancer?
Nature clinical practice. Oncology 2007;4(5):274-5.
2007: Di Maio Massimo; Perrone Francesco; Chiodini Paolo; Gallo Ciro; Camps Carlos; Schuette Wolfgang; Quoix Elisabeth; Tsai Chun-Ming; Gridelli Cesare
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1377-82.
2007: Gridelli Cesare; Kaukel Eckhard; Gregorc Vanessa; Migliorino Maria Rita; Müller Thomas R; Manegold Christian; Favaretto Adolfo; Martoni Andrea; Caffo Orazio; Schmittel Alexander; Rossi Antonio; Russo Francesca; Peterson Patrick; Muñoz María; Reck Martin
Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(3):221-9.
2007: Gridelli Cesare
Targeted therapies and non-small-cell lung cancer: new developments.
Current opinion in oncology 2007;19(2):75-7.
2007: Gridelli Cesare; Maione Paolo; Del Gaizo Filomena; Colantuoni Giuseppe; Guerriero Ciro; Ferrara Carmine; Nicolella Dario; Comunale Daniela; De Vita Alba; Rossi Antonio
Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer.
The oncologist 2007;12(2):191-200.
2007: Gridelli Cesare; Maione Paolo; Comunale Daniela; Rossi Antonio
Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer.
Cancer control : journal of the Moffitt Cancer Center 2007;14(1):57-62.
2007: Gridelli Cesare
The use of bisphosphonates in elderly cancer patients.
The oncologist 2007;12(1):62-71.
2006: Gridelli C; Rossi A; Maione P
New antiangiogenetic agents and non-small cell lung cancer.
Critical reviews in oncology/hematology 2006;60(1):76-86.
2006: Rossi Antonio; Maione Paolo; Gridelli Cesare
Cetuximab in advanced non-small cell lung cancer.
Critical reviews in oncology/hematology 2006;59(2):139-49.
2006: Gridelli C; Maione P; Rossi A; Guerriero C; Ferrara C; Del Gaizo F; Colantuoni G; Nicolella D; Napolitano L
Chemotherapy of advanced NSCLC in special patient population.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v72-8.
2006: Gridelli Cesare; Maione Paolo; Rossi Antonio
Treatment of stage I-III non-small-cell lung cancer in the elderly.
Oncology (Williston Park, N.Y.) 2006;20(4):373-80; discussion 385-6, 388, 393 passim.
2006: Rossi A; Gridelli C
Chemotherapy of advanced non-small cell lung cancer in elderly patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii58-60.
2006: De Petris L; Crinò L; Scagliotti G V; Gridelli C; Galetta D; Metro G; Novello S; Maione P; Colucci G; de Marinis F
Treatment of advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii36-41.
2006: Maione Paolo; Gridelli Cesare; Troiani Teresa; Ciardiello Fortunato
Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
The oncologist 2006;11(3):274-84.
2005: Rossi Antonio; Maione Paolo; Colantuoni Giuseppe; Gaizo Filomena Del; Guerriero Ciro; Nicolella Dario; Ferrara Carmine; Gridelli Cesare
Screening for lung cancer: New horizons?
Critical reviews in oncology/hematology 2005;56(3):311-20.
2005: Di Maio Massimo; Gridelli Cesare; Normanno Nicola; Perrone Francesco; Ciardiello Fortunato
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Journal of cellular physiology 2005;205(3):355-63.
2005: Rossi Antonio; Maione Paolo; Gridelli Cesare
Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.
Expert opinion on drug safety 2005;4(6):1051-67.
2005: Di Maio Massimo; Gridelli Cesare; Gallo Ciro; Shepherd Frances; Piantedosi Franco Vito; Cigolari Silvio; Manzione Luigi; Illiano Alfonso; Barbera Santi; Robbiati Sergio Federico; Frontini Luciano; Piazza Elena; Ianniello Giovanni Pietro; Veltri Enzo; Castiglione Federico; Rosetti Francesco; Gebbia Vittorio; Seymour Lesley; Chiodini Paolo; Perrone Francesco
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
The lancet oncology 2005;6(9):669-77.
2005: Gridelli Cesare; Shepherd Frances A
Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence.
Chest 2005;128(2):947-57.
2005: Rossi Antonio; Maione Paolo; Colantuoni Giuseppe; Guerriero Ciro; Ferrara Carmine; Del Gaizo Filomena; Nicolella Dario; Gridelli Cesare
Treatment of small cell lung cancer in the elderly.
The oncologist 2005;10(6):399-411.
2005: Gridelli C; Rossi A; Galetta D; Maione P; Ferrara C; Guerriero C; Del Gaizo F; Nicolella D; Colantuoni G; Gebbia V; Colucci G
Italian clinical research in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv110-115.
2005: Gridelli Cesare; Aapro Matti; Ardizzoni Andrea; Balducci Lodovico; De Marinis Filippo; Kelly Karen; Le Chevalier Thierry; Manegold Christian; Perrone Francesco; Rosell Rafael; Shepherd Frances; De Petris Luigi; Di Maio Massimo; Langer Corey
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3125-37.
2005: Gridelli C; Maione P; Rossi A; Ciardiello F; Raben D
Treatment of locally advanced non-small cell lung cancer in the elderly.
Current opinion in oncology 2005;17(2):130-4.
2005: Rossi Antonio; Maione Paolo; Del Gaizo Filomena; Guerriero Ciro; Castaldo Vincenzo; Gridelli Cesare
Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases.
Lung cancer (Amsterdam, Netherlands) 2005;47(3):421-3.
2005: De Marinis Filippo; Nelli Fabrizio; Lombardo Marco; Ferraú Francesco; Barbera Santi; Bertetto Oscar; Barni Sandro; Michetti Giovanni; Labianca Roberto; Gridelli Cesare
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.
Cancer 2005;103(4):772-9.
2005: Rossi A; Colantuoni G; Maione P; Ferrara C; Airoma G; Barzelloni M L; Castaldo V; Gridelli C
Chemotherapy of breast cancer in the elderly.
Current medicinal chemistry 2005;12(3):297-310.
2004: Gridelli C; Gallo C; Di Maio M; Barletta E; Illiano A; Maione P; Salvagni S; Piantedosi F V; Palazzolo G; Caffo O; Ceribelli A; Falcone A; Mazzanti P; Brancaccio L; Capuano M A; Isa L; Barbera S; Perrone F
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.
British journal of cancer 2004;91(12):1996-2004.
2004: Gridelli C; Manegold C; Mali P; Reck M; Portalone L; Castelnau O; Stahel R; Betticher D; Pless M; Pons J Terrassa; Aubert D; Burillon J-P; Parlier Y; De Marinis F
Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.
European journal of cancer (Oxford, England : 1990) 2004;40(16):2424-31.
2004: Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
The role of new targeted therapies in small-cell lung cancer.
Critical reviews in oncology/hematology 2004;51(1):45-53.
2004: Maione Paolo; Rossi Antonio; Airoma Giuseppe; Ferrara Carmine; Castaldo Vincenzo; Gridelli Cesare
The role of targeted therapy in non-small cell lung cancer.
Critical reviews in oncology/hematology 2004;51(1):29-44.
2004: Gridelli Cesare; Aapro Matti
Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(7):487-96.
2004: Di Maio M; Gridelli C; Gallo C; Manzione L; Brancaccio L; Barbera S; Robbiati S F; Ianniello G P; Ferraù F; Piazza E; Frontini L; Rosetti F; Carrozza F; Bearz A; Spatafora M; Adamo V; Isa L; Iaffaioli R V; Di Salvo E; Perrone F
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.
British journal of cancer 2004;90(12):2288-96.
2004: Gridelli Cesare; Rossi Antonio; Maione Paolo; Guerriero Ciro; Airoma Giuseppe; Colantuoni Giuseppe; Barzelloni Maria Luisa
Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use program.
Anticancer research 2004;24(3b):1873-7.
2004: Gridelli Cesare
[Medical therapy of elderly patients with advanced non-small cell lung carcinoma: significance and possibilities]
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(2):S36-7.
2004: Gridelli C; Ardizzoni A; Le Chevalier T; Manegold C; Perrone F; Thatcher N; van Zandwijk N; Di Maio M; Martelli O; De Marinis F
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):419-26.
2004: Rossi Antonio; Colantuoni Giuseppe; Cantore Nicola; Panico Luigi; De Chiara Giovanni; Ferbo Umberto; Gridelli Cesare
Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case.
Anticancer research 2004;24(1):317-9.
2004: Gridelli Cesare
Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics.
Drugs & aging 2004;21(13):825-32.
2003: Gridelli C; Maione P; Castaldo V; Rossi A
Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer.
British journal of cancer 2003;89(10):1827-9.
2003: De Marinis Filippo; Nelli Fabrizio; Migliorino Maria Rita; Martelli Olga; Cortesi Enrico; Treggiari Stefano; Portalone Luigi; Crispino Carlo; Brancaccio Luigi; Gridelli Cesare
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.
Cancer 2003;98(8):1707-15.
2003: Gridelli Cesare; Rossi Antonio; Maione Paolo
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
Oncogene 2003;22(42):6629-38.
2003: Nicolella D; Maione P; Gridelli C
Targeted therapies: focus on a new strategy for gastrointestinal tumors.
Critical reviews in oncology/hematology 2003;47(3):261-71.
2003: Gridelli Cesare; Gallo Ciro; Shepherd Frances A; Illiano Alfonso; Piantedosi Francovito; Robbiati Sergio Federico; Manzione Luigi; Barbera Santi; Frontini Luciano; Veltri Enzo; Findlay Brian; Cigolari Silvio; Myers Robert; Ianniello Giovanni P; Gebbia Vittorio; Gasparini Giampietro; Fava Sergio; Hirsh Vera; Bezjak Andrea; Seymour Lesley; Perrone Francesco
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2003: Ceribelli Anna; Gridelli Cesare; De Marinis Filippo; Fabi Alessandra; Gamucci Teresa; Cortesi Enrico; Barduagni Maria; Antimi Mauro; Maione Paolo; Migliorino Maria R; Giannarelli Diana; Cognetti Francesco
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
Cancer 2003;98(2):337-43.
2003: Gridelli Cesare
5-HT3-receptor antagonists in the control of delayed-onset emesis.
Anticancer research 2003;23(3C):2773-82.
2003: Rossi Antonio; Gridelli Cesare; Gebbia Vittorio; Rosati Gerardo; Tortoriello Anna; Maione Paolo; Borsellino Nicola; Rossi Nestore; Pisano Agata; Colantuoni Giuseppe; Iaffaioli Rosario Vincenzo; Castaldo Vincenzo; Manzione Luigi
Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
Anticancer research 2003;23(2C):1657-64.
2003: Gridelli Cesare; Perrone Francesco; Gallo Ciro; Cigolari Silvio; Rossi Antonio; Piantedosi Francovito; Barbera Santi; Ferraù Francesco; Piazza Elena; Rosetti Francesco; Clerici Maurizia; Bertetto Oscar; Robbiati Sergio Federico; Frontini Luciano; Sacco Cosimo; Castiglione Federico; Favaretto Adolfo; Novello Silvia; Migliorino Maria Rita; Gasparini Giampietro; Galetta Domenico; Iaffaioli Rosario Vincenzo; Gebbia Vittorio;
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Journal of the National Cancer Institute 2003;95(5):362-72.
2002: Gridelli Cesare; Hainsworth John
Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 4():37-41.
2002: Gridelli Cesare
Chemotherapy of non-small cell lung cancer in the elderly.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 3():S67-70.
2002: Gridelli Cesare
Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 2():S45-50.
2002: Scagliotti G V; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Matano E; Boni C; Marangolo M; Failla G; Altavilla G; Adamo V; Ceribelli A; Clerici M; Di Costanzo F; Frontini L; Tonato M;
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4285-91.
2002: Gridelli C; Maione P; Airoma G; Rossi A
Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer.
Current medicinal chemistry 2002;9(21):1851-8.
2002: Montella Maurizio; Gridelli Cesare; Crispo Anna; Scognamiglio Francesco; Ruffolo Pasquale; Gatani Tindaro; Boccia Vincenzo; Maione Paolo; Fabbrocini Gabriella
Has lung cancer in the elderly different characteristics at presentation?
Oncology reports 2002;9(5):1093-6.
2002: Gridelli C; Maione P; Colantuoni G; Rossi A
Chemotherapy of non-small cell lung cancer in elderly patients.
Current medicinal chemistry 2002;9(16):1487-95.
2002: Gridelli Cesare; Rossi Antonio; Guerriero Ciro; Nicolella Dario; Ferrara Carmine; Del Gaizo Filomena; Colantuoni Giuseppe; Airoma Giuseppe; Maione Paolo
Oral cytotoxic drugs.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S19-23.
2002: Gridelli Cesare; Rossi Antonio; Barletta Emiddio; Panza Nicola; Brancaccio Luigi; Cioffi Riccardo; Pedicini Tonino; Ianniello Giovanni Pietro; Piazza Elena; Rossi Nestore; Iaffaioli Rosario Vincenzo; Maione Paolo; Di Maio Massimo; Gallo Ciro; Perrone Francesco
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2002;36(3):327-32.
2002: Gridelli Cesare; De Vivo Rocco
Vinorelbine in the treatment of non-small cell lung cancer.
Current medicinal chemistry 2002;9(8):879-91.
2002: Gridelli Cesare; Ferrara Carmine; Del Gaizo Filomena; Guerriero Ciro; Nicolella Dario; Colantuoni Giuseppe; Rossi Antonio
Chemotherapy of advanced NSCLC in the elderly.
Tumori 2002;88(1 Suppl 1):S143-4.
2001: Gridelli C; Curcio C; Iaffaioli R V; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Anticancer research 2001;21(6A):4179-83.
2001: Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello G P; Frontini L; Ferraù F; Robbiati S F; Adamo V; Gasparini G; Novello S; Perrone F;
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;31(2-3):277-84.
2001: Gridelli C; Manzione L; Perrone F; Veltri E; Cioffi R; Caprio M G; Frontini L; Rossi A; Barletta E; Barzelloni M L; Bilancia D; Gallo C
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study.
British journal of cancer 2001;84(1):38-41.
2001: Gridelli C; Perrone F; Nelli F; Ramponi S; De Marinis F
Quality of life in lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12 Suppl 3():S21-5.
2000: Gridelli C; Daniele B
Originality, benefits and difficulties of clinical research performed by cooperative groups: the experience of an Italian Lung Cancer Study Group.
Critical reviews in oncology/hematology 2000;36(1):3-8.
2000: Illiano A; Barletta E; De Marino V; Battiloro C; Barzelloni M; Scognamiglio F; Rossi N; Zampa G; De Bellis M; Gridelli C
New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study.
Anticancer research 2000;20(5C):3999-4003.
2000: Gridelli C
Chemotherapy of advanced non small cell lung cancer in the elderly: an update.
Critical reviews in oncology/hematology 2000;35(3):219-25.
2000: Gridelli C; Frontini L; Perrone F; Gallo C; Gulisano M; Cigolari S; Castiglione F; Robbiati S F; Gasparini G; Ianniello G P; Farris A; Locatelli M C; Felletti R; Piazza E
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators.
British journal of cancer 2000;83(6):707-14.
2000: Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni M L; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
Lung cancer (Amsterdam, Netherlands) 2000;29(2):131-7.
2000: Gridelli C; Cigolari S; Maiorino A; Ianniello G P; Brancaccio L; Rossi A; De Cataldis G; Pedicini T; Maiorino L; Barletta E; Di Lanno M; Bilancia D; Crispino C; Barzelloni M L; Masullo P; D'Aniello R; Manzione L
Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2000;28(3):237-44.
2000: Gridelli C; Frontini L; Barletta E; Rossi A; Barzelloni M L; Scognamiglio F; Guida C; Gatani T; Fiore F; De Bellis M; Marfella A; Manzione L
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.
Anticancer research 2000;20(2B):1077-84.
1999: Gridelli C
[Topotecan, a recent discovery and prospects for treating tumors of the lung]
Tumori 1999;85(6 Suppl 1):S16-22.
1999: Crinò L; Scagliotti G V; Ricci S; De Marinis F; Rinaldi M; Gridelli C; Ceribelli A; Bianco R; Marangolo M; Di Costanzo F; Sassi M; Barni S; Ravaioli A; Adamo V; Portalone L; Cruciani G; Masotti A; Ferrara G; Gozzelino F; Tonato M
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3522-30.
1999: Gridelli C; Perrone F; Gallo C; Rossi A; Barletta E; Barzelloni M L; Creazzola S; Gatani T; Fiore F; Guida C; Scognamiglio F
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial.
Anticancer research 1999;19(5C):4535-8.
1999: Gridelli C; Barzelloni M L; Barletta E; Guida C; Gatani T; Fiore F; Scognamiglio F
The role of granulocyte growth factors in the treatment of non small cell lung cancer.
La Clinica terapeutica 1999;150(3):231-4.
1998: Ruckdeschel J C; Gridelli C; Perrone F; Monfardini S; Giaccone G
Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?
European journal of cancer (Oxford, England : 1990) 1998;34(13):1993-9.
1998: Gridelli C; Perrone F; Ianniello G P; Brancaccio L; Iaffaioli R V; Curcio C; D'Aprile M; Cioffi R; Cigolari S; Rossi A; Palazzolo G; Veltri E; Pergola M; De Placido S; Gallo C; Monfardini S; Bianco A R
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1414-9.
1997: Gridelli C; Perrone F; Monfardini S
Lung cancer in the elderly.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2313-4.
1997: Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
Anticancer research 1997;17(6D):4755-8.
1997: Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco A R; Pergola M; Monfardini S
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
European journal of cancer (Oxford, England : 1990) 1997;33(3):392-7.
1997: Gridelli C; De Marinis F; Rossi A; Tucci E; D'Aprile M; Cioffi R; Cortesi E; Migliorino R; Pisano A; Scognamiglio F; Di Giacomo R; Bianco A R
A phase II study of VM-26 plus lonidamine in pretreated small cell lung cancer.
Anticancer research 1997;17(2B):1277-9.
1996: Gridelli C; D'Aprile M; Palmeri S; Curcio C; Rossi A; Gebbia V; Veltri E; Pepe R; Pistillucci G; Bianco A R
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
American journal of clinical oncology 1996;19(6):589-91.
1996: Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto A F; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco A R
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):821-6.
1996: Gridelli C; Rossi A; Incoronato P; Bruni G S; Scognamiglio F; Ruffolo P; Rinaldi L; Bianco A R
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1996;37(6):613-5.
1995: Gridelli C; Perrone F; D'Aprile M; Rossi A; Palmeri S; Curcio C; Veltri E; Ianniello G; Lorusso V; Palmieri G
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2424-6.
1994: Gridelli C; D'Aprile M; Curcio C; Brancaccio L; Palmeri S; Comella G; Veltri E; Ferrante G; Gentile M; Rossi A
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Lung cancer (Amsterdam, Netherlands) 1994;11(1-2):83-91.
1994: Perrone F; De Placido S; Carlomagno C; Gravina A; De Laurentiis M; Del Mastro L; Gridelli C; Pagliarulo C; Bianco A R
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
American journal of clinical oncology 1994;17(3):218-22.
1994: Gridelli C; Ianniello G P; Maiorino A; Curcio C; D'Aprile M; Brancaccio L; Palmeri S; Gentile M; Comella G; Pedicini T
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
American journal of clinical oncology 1994;17(2):160-2.
1994: Gridelli C; Rossi A; Palazzolo G; Pepe R; Airoma G; Incoronato P; Bianco A R
Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non small cell lung cancer.
Tumori 1994;80(2):128-30.
1993: Perrone F; De Placido S; Carlomagno C; Nuzzo F; Ruggiero A; De Laurentiis M; Gridelli C; Pagliarulo C; Bianco A R
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
Tumori 1993;79(4):254-7.
1993: Gridelli C; Incoronato P; Airoma G; Pepe R; Arpinelli F; Bianco A R
Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy.
European journal of cancer (Oxford, England : 1990) 1993;29A(4):651.
1993: Gridelli C; De Placido S; Pepe R; Incoronato P; Airoma G; Rossi A; Palazzolo G; Bianco A R
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1729-31.
1992: Gridelli C; Iacobelli S; Martino T; Natoli C; Ferrante G; Gentile M; Irtelli L; Beltrami V; Rossi A; Bianco A R
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot study.
Tumori 1992;78(6):377-9.
1992: Gridelli C; Pepe R; Airoma G; Incoronato P; Rossi A; Palazzolo G; Bianco A R
Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma.
Tumori 1992;78(6):380-2.
1992: Gridelli C; Airoma G; Incoronato P; Pepe R; Palazzolo G; Rossi A; Bianco A R
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1992;30(3):212-4.
1991: Gridelli C; Contegiacomo A; Lauria R; Gentile M; Airoma G; De Placido S; Perrone F; Ferrante G; Bianco A R
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
Tumori 1991;77(6):506-10.
1991: Bianco A R; Stefani S; Gridelli C; Gentile M; Contegiacomo A; Giampaglia F; Lauria R; Conte A; Ferrante G
Intensive alternating combination chemotherapy and high dose chest radiotherapy in small cell lung cancer.
Tumori 1991;77(5):437-41.
1991: Palmieri G; Gridelli C; Airoma G; Pepe R; Incoronato P; Caponigro F; Bianco A R
Second-line chemotherapy of advanced colorectal cancer with sequential high-dose methotrexate and 5-fluorouracil.
Journal of chemotherapy (Florence, Italy) 1991;3(1):55-60.
1991: Gridelli C; Pepe R; Palmeri S; Iacobelli S; Gentile M; Gebbia V; Garufi C; Airoma G; Palmieri G; Russo A
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1991;28(5):405-7.
1990: Palmieri G; Caponigro F; Iaffaioli R V; Contegiacomo A; Montesarchio V; Lauria R; Calderopoli R; Pagliarulo C; Gridelli C; Bianco A R
CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: final results of a pilot study.
Hematological oncology 1990;8(6):313-22.
1990: Palmieri G; Lauria R; Caponigro F; Pagliarulo C; Montesarchio V; Nuzzo F; Gridelli C; Bianco A R
Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of CCNU and vinblastine.
Hematological oncology 1990;8(4):179-83.
1990: Gridelli C; Palmieri G; Airoma G; Incoronato P; Pepe R; Barra E; Bianco A R
Complete regression of laryngeal involvement by classic Kaposi's sarcoma with low-dose alpha-2b interferon.
Tumori 1990;76(3):292-3.
1990: Palmieri G; Gridelli C; Pepe R; Airoma G; Iaffaioli R V; Frasci G; Caponigro F; Bianco A R
Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
Tumori 1990;76(1):61-3.
1990: Palmieri G; Gridelli C; Airoma G; Balestrino M; Bisogno A; Incoronato P; Bianco A R
Clinical trial with 5-fluorouracil and leucovorin.
Journal of chemotherapy (Florence, Italy) 1990;2 Suppl 1():41-6.
1989: Palmieri G; Stefani S; Gridelli C; Conte A; Airoma G; Contegiacomo A; Bianco A R
Irradiation of the hypothalamic-hypophyseal area induces complete regression of mucocutaneous lesions in disseminated histiocytosis X.
Cancer 1989;64(1):29-31.
1988: Palmieri G; Gridelli C; Vitale A; Bianco A R
Contemporary chemotherapy and radiotherapy for inguinal metastases of carcinoma of the penis: a case report.
Tumori 1988;74(5):585-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Cesare Gridelli

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Cesare Gridelli (preview)

All Publications